These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 27893008)

  • 1. Use of Genetic Testing in Amyotrophic Lateral Sclerosis by Neurologists.
    Arthur KC; Doyle C; Chiò A; Traynor BJ
    JAMA Neurol; 2017 Jan; 74(1):125-126. PubMed ID: 27893008
    [No Abstract]   [Full Text] [Related]  

  • 2. Patients with sporadic and familial amyotrophic lateral sclerosis found value in genetic testing.
    Wagner KN; Nagaraja HN; Allain DC; Quick A; Kolb SJ; Roggenbuck J
    Mol Genet Genomic Med; 2018 Mar; 6(2):224-229. PubMed ID: 29266834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The complex genetics of amyotrophic lateral sclerosis.
    Hardiman O; Greenway M
    Lancet Neurol; 2007 Apr; 6(4):291-2. PubMed ID: 17362828
    [No Abstract]   [Full Text] [Related]  

  • 4. Motor neuron disease: Genetic testing in amyotrophic lateral sclerosis.
    Ludolph AC
    Nat Rev Neurol; 2017 May; 13(5):262-263. PubMed ID: 28387338
    [No Abstract]   [Full Text] [Related]  

  • 5. Familial amyotrophic lateral sclerosis from north India: case report and brief review.
    Kulshreshtha D; Singh AK; Maurya PK; Thacker AK
    Neurol India; 2014; 62(2):210-1. PubMed ID: 24823743
    [No Abstract]   [Full Text] [Related]  

  • 6. Physician perceptions about living organ donation in patients with Amyotrophic Lateral Sclerosis.
    Ansari S; Bromberg MB; Gibson SB
    Clin Neurol Neurosurg; 2017 Sep; 160():125-129. PubMed ID: 28727995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictive genetic testing for amyotrophic lateral sclerosis and frontotemporal dementia: genetic counselling considerations.
    Crook A; Williams K; Adams L; Blair I; Rowe DB
    Amyotroph Lateral Scler Frontotemporal Degener; 2017 Nov; 18(7-8):475-485. PubMed ID: 28585888
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of consensus in ALS genetic testing practices and divergent views between ALS clinicians and patients.
    Klepek H; Nagaraja H; Goutman SA; Quick A; Kolb SJ; Roggenbuck J
    Amyotroph Lateral Scler Frontotemporal Degener; 2019 May; 20(3-4):216-221. PubMed ID: 30931630
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patients with Amyotrophic Lateral Sclerosis Have High Interest in and Limited Access to Genetic Testing.
    Wagner KN; Nagaraja H; Allain DC; Quick A; Kolb S; Roggenbuck J
    J Genet Couns; 2017 Jun; 26(3):604-611. PubMed ID: 27761850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Home ventilation for amyotrophic lateral sclerosis patients: outcomes, costs, and patient, family, and physician attitudes.
    Moss AH; Casey P; Stocking CB; Roos RP; Brooks BR; Siegler M
    Neurology; 1993 Feb; 43(2):438-43. PubMed ID: 8437718
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ethical considerations in the management of amyotrophic lateral sclerosis.
    Eisen A; Krieger C
    Prog Neurobiol; 2013 Nov; 110():45-53. PubMed ID: 23735671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening of OPTN in French familial amyotrophic lateral sclerosis.
    Millecamps S; Boillée S; Chabrol E; Camu W; Cazeneuve C; Salachas F; Pradat PF; Danel-Brunaud V; Vandenberghe N; Corcia P; Le Forestier N; Lacomblez L; Bruneteau G; Seilhean D; Brice A; Feingold J; Meininger V; LeGuern E
    Neurobiol Aging; 2011 Mar; 32(3):557.e11-3. PubMed ID: 21220178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Journey with Amyotrophic Lateral Sclerosis.
    J Christ Nurs; 2018; 35(3):E43-E44. PubMed ID: 29863525
    [No Abstract]   [Full Text] [Related]  

  • 14. "You have shown me my end": attitudes toward presymptomatic testing for familial amyotrophic lateral sclerosis.
    Fanos JH; Gelinas DF; Miller RG
    Am J Med Genet A; 2004 Sep; 129A(3):248-53. PubMed ID: 15326623
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening of the regulatory and coding regions of vascular endothelial growth factor in amyotrophic lateral sclerosis.
    Brockington A; Kirby J; Eggitt D; Schofield E; Morris C; Lewis CE; Ince PG; Shaw PJ
    Neurogenetics; 2005 May; 6(2):101-4. PubMed ID: 15776280
    [No Abstract]   [Full Text] [Related]  

  • 16. Screening the metallothionein III gene in sporadic amyotrophic lateral sclerosis.
    Morahan JM; Yu B; Trent RJ; Pamphlett R
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2005 Jun; 6(2):115-7. PubMed ID: 16036436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identify mutation in amyotrophic lateral sclerosis cases using HaloPlex target enrichment system.
    Liu ZJ; Li HF; Tan GH; Tao QQ; Ni W; Cheng XW; Xiong ZQ; Wu ZY
    Neurobiol Aging; 2014 Dec; 35(12):2881.e11-2881.e15. PubMed ID: 25109764
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost effectiveness: summary.
    Ringel SP
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2002; 3 Suppl 1():S67-9. PubMed ID: 12396813
    [No Abstract]   [Full Text] [Related]  

  • 19. [Genetic counselling is relevant in familial as well as sporadic cases of amyotrophic lateral sclerosis].
    Lindquist SG; Dunø M; Svenstrup K; Nielsen JE
    Ugeskr Laeger; 2014 Oct; 176(43):. PubMed ID: 25353674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Familial frontotemporal dementia and amyotrophic lateral sclerosis associated with the C9ORF72 hexanucleotide repeat.
    Hodges J
    Brain; 2012 Mar; 135(Pt 3):652-5. PubMed ID: 22366789
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.